norfluoxetine has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, YC; Jin, BK; Kim, KI | 1 |
Gross, S; Oh, JE; Toth, M; Zupan, B | 1 |
Harasztosi, C; Kecskeméti, V; Nánási, PP; Pál, B; Riba, P; Rusznák, Z; Szûcs, G; Wagner, R | 1 |
3 other study(ies) available for norfluoxetine and Disease Models, Animal
Article | Year |
---|---|
Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Fluoxetine; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2018 |
Paradoxical anxiogenic response of juvenile mice to fluoxetine.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Cell Proliferation; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Drug Administration Schedule; Exploratory Behavior; Fluoxetine; Infusion Pumps, Implantable; Male; Maze Learning; Mice; Mice, Inbred Strains; Reaction Time; Selective Serotonin Reuptake Inhibitors; Swimming | 2009 |
Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.
Topics: Animals; Anticonvulsants; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Clonazepam; Cochlear Nucleus; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Fluoxetine; Male; Membrane Potentials; Mice; Neurons, Afferent; Patch-Clamp Techniques; Phenytoin; Selective Serotonin Reuptake Inhibitors | 2005 |